YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Illumina, BGI Battle Over Complete Genomics


November 27, 2012 | The fight for Complete Genomics is not over. BGI and Illumina have both submitted letters arguing that their offer is a better fit to the Complete Genomics board. Illumina has offered a better price, and pointed out that an Illumina-Complete Genomics deal would not be subject to foreign investment oversight. BGI accused Illumina of being anticompetitive and making false allegations. Nature News
View Next Related Story
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.